Published on 14 May 2024
De novo belatacept does not reduce the rate of skin cancer in renal transplant recipients compared to standard therapy (Supplemental Material)
View DatasetJew, Olivia
Description
Supplemental data.
Citations (0)
No citations found
It looks like this dataset has no citations.
Mentions (0)
No mentions found
It looks like this dataset has not been mentioned in any sources.
Metrics Over Time
Publication Details
Subfield
Transplantation
Field
Medicine
Domain
Health Sciences
Confidence Score
58%
Source
Scholar Data Model
Keywords
DermatologySkin CancerOrgan TransplantationImmunosuppression